Abstract:BackgroundDuchenne Muscular Dystrophy (DMD) is the most common muscle disease in children, and there are no effective therapies for DMD or Becker Muscular Dystrophy (BMD). Currently, targeted gene therapy treatments have emerged. As a result, genetic diagnosis is the basis of treatment. In addition, genetic and prenatal diagnosis significantly reduces their incidence rates. This study combines the application of multiplex ligation-dependent probe amplification technology (MLPA) and "next-generation" sequencing technology (NGS) as the most economical and efficient method of diagnosis. Therefore, in the diagnosis of DMD/BMD, patients' MLPA data are first used to detect DMD gene deletions or duplications, and NGS and Sanger sequencing are then applied to exclude MLPA-negative samples. Meanwhile, polymerase chain reaction (PCR) is used to detect single exon deletions to exclude false-positives in MLPA caused by point mutations.MethodsIn this study, we recruited 1051 proband families of DMD from 2016 to 2018 and had access to information that could identify individual participants during or after data collection. Patients who were diagnosed with DMD were first tested by MLPA. MLPA results with single exon deletions were validated with PCR amplification and Sanger sequencing. The negative results of MLPA were further analysed with NGS and validated by Sanger sequencing. For novel missense mutations, phenotype-genotype correlations were analysed using PolyPhen2 and mutation taster. All methods were performed in accordance with the relevant guidelines and regulations.ResultsDMD mutations were identified in 1029 families (97.91%, 1029/1051). Large deletions, duplications, and small mutations accounted for 70.41% (740/1051), 8.28% (87/1051), and 19.12% (201/1051) of all cases, respectively. There were 205 small mutation types, 53 of which were novel. The rate of de novo mutations was 39.45% (187/474) and was higher in large duplications (49.53%, 157/317). Among 68 asymptomatic patients (< 3 years old) with unexplained persistent hyperCKaemia upon conventional physical examination, 63 were diagnosed as DMD/BMD according to genetic diagnosis.ConclusionOur results expand the spectrum of DMD mutations, which could contribute to the treatment of DMD/BMD and provide an effective diagnosis method. Thus, the combination of MLPA, NGS and Sanger sequencing is of great significance for family analysis, gene diagnosis and gene therapy.

[Clinical and Pathological Features of 50 Children with Duchenne's Muscular Dystrophy].

Changes of Dystrophin Expression in Muscle of Patients with DMD and Its Relevance to Clinical Pathology

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Clinical, Molecular Pathological and Genetic Analysis of a Chinese Family with Dystrophinopathy

Progressive muscular dystrophy: an analysis of 42 cases

Clinical, Myopathological and Genetic Features in Five Female Manifesting Carriers of Duchenne Muscular Dystrophy

Clinical and Pathological Features of Muscular Dystrophy Congenital 1A

Clinical Diagnosis and Genetic Analysis of Children With Muscular Dystrophies

Clinical Features in Boys with Duchenne/Becker Muscular Dystrophy: A Tertiary Center Experience

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

Ultrastructural features of skeletal muscle in the patients with Duchenne/Becker muscular dystrophy

[Genotype, Phenotype Analysis and Follow-Up Study on Patients with Duchenne/Becker Muscular Dystrophy].

Cardiac Dysfunction with Duchenne's Muscular Dystrophy:406 Cases Studied

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Duchenne muscular dystrophy: pathogenesis and promising therapies

Clinical and Pathological Features in 3 Chinese Patients with Ullrich Congenital Muscular Dystrophy

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells

Occurrence Rule of Major Lifetime Events of Children with Duchenne Muscular Dystrophy

Dystrophin Detection by Immunofiuorescent Technique for Diagnosing Duchenne Muscular Dystrophy/Becker Muscular Dystrophy and Duchenne Muscular Dystrophy Carrier

Current research status and prospect in diagnosis of children with Duchenne muscular dystrophy by high-frequency ultrasound and shear wave elasticity imaging